Catalyst Wire Dossier Catalyst Wire Dossier

AFP³³²T

AFPc33 · Adaptimmune
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AFP³³²T, covering 2026-06-17 to 2026-06-17. Get the full timeline:

Most recent: Clinical Trial Results: AFPᶜ³³²T in Advanced HCC [Phase 1]

See pricing